PRNP and prion disease: Thus the amino-terminal PrP substitution induced an excitatory clinical phenotype and an early-onset neurodegeneration characterized by synapse loss, neuronal death, astro- and microgliosis, and spongiform encephalopathy, with the most severe lesions in the hippocampus (CA1), cerebral cortex, thalamus, and brainstem.